Sandoz Group Ltd (SDZXF) Price & Analysis

Compare

12 Followers

SDZXF Stock Chart & Stats

$86.18

$0.00(0.00%)

At close: Jan 06 4:00 PM EST

$86.18

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$35.35 - $88.97

Previous CloseN/A

Volume50.00

Average Volume (3M)65.00

Market Cap

$37.81B

Enterprise Value$41.53B

Total Cash (Recent Filing)$1.39B

Total Debt (Recent Filing)$5.69B

Price to Earnings (P/E)164.7

Beta0.48

Next Earnings

Feb 25, 2026

EPS Estimate

1.73

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.46

Shares Outstanding440,000,000

10 Day Avg. Volume115

30 Day Avg. Volume65

Financial Highlights & Ratios

PEG Ratio-176.07

Price to Book (P/B)2.16

Price to Sales (P/S)1.93

P/FCF Ratio293.45

Enterprise Value/Market Cap1.10

Enterprise Value/Revenue4.45

Enterprise Value/Gross Profit9.56

Enterprise Value/Ebitda57.01

Forecast

1Y Price Target

$81.78

Price Target Upside-5.11% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering8

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue GrowthSandoz’s ~27% top-line expansion demonstrates durable demand for its off-patent portfolio and successful product launches. Sustained revenue growth supports scale economics, funds manufacturing and biosimilar commercialization, and improves bargaining power in tender and institutional channels long-term.

Broad Generics & Biosimilars PortfolioA diversified mix of small-molecule generics and biosimilars across retail, hospital and tender channels reduces reliance on any single market or product. This structural diversification supports resilient volumes, cross-market scale benefits and a pathway to higher-value biosimilar sales over multiple quarters to years.

Stable Gross MarginA roughly 47% gross margin signals sustained manufacturing efficiency and pricing power on core products. That structural margin base enables investment in complex generics and biosimilar capacity, cushioning operating volatility and providing a foundation for improving upstream profitability over the medium term.

Bears Say

Extremely Low Net ProfitabilityAn almost zero net margin severely limits retained earnings and resilience to cost shocks. Persistent near-break-even profitability constrains reinvestment in R&D and commercialization, weakens ability to fund biosimilar uptake, and leaves the business vulnerable to pricing or input-cost pressures over time.

Weak Cash ConversionA >50% drop in free cash flow shows earnings are not converting into spendable cash reliably. Structural weakness in cash generation impairs the company’s ability to service obligations, invest in capacity or new launches, and may necessitate external financing or austerity measures that hamper strategic plans.

Poor ROE And Historical DebtNegligible return on equity combined with historically elevated debt levels points to subpar capital efficiency and prior leverage risks. Even with moderate current gearing, low ROE limits shareholder value creation and reduces financial flexibility to invest or absorb shocks, pressuring long-term strategy execution.

Sandoz Group Ltd News

Sandoz receives U.S. FDA approval to expand Enzeevu label

Sandoz (SDZNY) announced that the US Food and Drug Administration, FDA, has approved an expanded label for Enzeevu,...

4d ago

Sandoz upgraded to Buy from Hold at Jefferies

Jefferies analyst James Vane-Tempest upgraded Sandoz (SDZNY) to Buy from Hold with a price target of CHF 75,...

10d ago

Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Sandoz (SDZNY) to CHF 63 from CHF 60 and keeps...

30d ago

Sandoz price target raised to CHF 55 from CHF 49 at Berenberg

Berenberg raised the firm’s price target on Sandoz (SDZNY) to CHF 55 from CHF 49 and keeps a...

30d ago

Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar

Sandoz Group Ltd ( ($CH:SDZ) ) has shared an announcement. Sandoz has secured U.S. FDA approval to expand...

4d ago

Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank

Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Sandoz (SDZNY) to CHF 63 from CHF...

1M ago

Sandoz Wins EU Approval for Ondibta Biosimilar Insulin, Bolstering Diabetes Push

Sandoz Group Ltd ( ($CH:SDZ) ) just unveiled an update. Sandoz has secured European Commission marketing authorization for...

1M ago

Sandoz Targets ‘Golden Decade’ as Patent Cliff Opens USD 600 Billion Generics and Biosimilars Opportunity

Sandoz Group Ltd ( ($CH:SDZ) ) has provided an announcement. Sandoz plans to leverage its status as the...

1M ago

Sandoz price target raised to CHF 70 from CHF 55 at Barclays

Barclays raised the firm’s price target on Sandoz (SDZNY) to CHF 70 from CHF 55 and keeps an...

2M ago

Sandoz initiated with a Neutral at Oddo BHF

Oddo BHF analyst Martial Descoutures initiated coverage of Sandoz (SDZNY) with a Neutral rating and CHF 57 price...

2M ago

Sandoz’s New Asthma Treatment Study: A Potential Game-Changer?

Sandoz Group Ltd ($SDZXF) announced an update on their ongoing clinical study. Study Overview: Sandoz Group Ltd is...

2M ago

SDZXF

Sandoz Strengthens Biosimilars Leadership with Key Acquisition

The latest update is out from Sandoz Group Ltd ( ($CH:SDZ) ). Sandoz has completed the acquisition of...

3M ago

Sandoz Launches Denosumab Biosimilars in Europe to Expand Affordable Treatment Options

Sandoz Group Ltd ( ($CH:SDZ) ) has shared an update. Sandoz has launched Wyost® and Jubbonti®, two denosumab...

3M ago

Sandoz Expands European Market with Afqlir® Launch for Retinal Diseases

The latest announcement is out from Sandoz Group Ltd ( ($CH:SDZ) ). Sandoz has launched Afqlir® (aflibercept) in...

3M ago

SDZXF FAQ

What was Sandoz Group Ltd’s price range in the past 12 months?

Sandoz Group Ltd lowest stock price was $35.35 and its highest was $88.97 in the past 12 months.

What is Sandoz Group Ltd’s market cap?

Sandoz Group Ltd’s market cap is $37.81B.

When is Sandoz Group Ltd’s upcoming earnings report date?

Sandoz Group Ltd’s upcoming earnings report date is Feb 25, 2026 which is in 3 days.

How were Sandoz Group Ltd’s earnings last quarter?

Sandoz Group Ltd released its earnings results on Aug 08, 2024. The company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1 by $0.12.

Is Sandoz Group Ltd overvalued?

According to Wall Street analysts Sandoz Group Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sandoz Group Ltd pay dividends?

Sandoz Group Ltd does not currently pay dividends.

What is Sandoz Group Ltd’s EPS estimate?

Sandoz Group Ltd’s EPS estimate is 1.73.

How many shares outstanding does Sandoz Group Ltd have?

Sandoz Group Ltd has 440,000,000 shares outstanding.

What happened to Sandoz Group Ltd’s price movement after its last earnings report?

Sandoz Group Ltd reported an EPS of $1.12 in its last earnings report, beating expectations of $1. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Sandoz Group Ltd?

Currently, no hedge funds are holding shares in SDZXF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sandoz Group Ltd

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

Sandoz Group Ltd (SDZXF) Earnings & Revenues

Historic Earnings Reports

SDZXF Stock 12 Month Forecast

Average Price Target

$81.78

▼(-5.11% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","68":"$68","97":"$97","53.5":"$53.5","82.5":"$82.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":96.696525,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$96.70</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":81.78,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$81.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.46435,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$64.46</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,53.5,68,82.5,97],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.425,79.83050192307692,81.23600384615385,82.64150576923076,84.04700769230769,85.45250961538461,86.85801153846154,88.26351346153845,89.66901538461538,91.0745173076923,92.48001923076923,93.88552115384614,95.29102307692307,{"y":96.696525,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.425,78.68307692307692,78.94115384615384,79.19923076923077,79.4573076923077,79.71538461538461,79.97346153846154,80.23153846153846,80.48961538461539,80.7476923076923,81.00576923076923,81.26384615384616,81.52192307692307,{"y":81.78,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,78.425,77.35110384615385,76.27720769230768,75.20331153846153,74.12941538461538,73.05551923076922,71.98162307692307,70.90772692307692,69.83383076923076,68.75993461538461,67.68603846153846,66.6121423076923,65.53824615384615,{"y":64.46435,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":47.06,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":42.57,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.51,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.41,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.13,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.94,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.62,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.45,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.5,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.98,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.84,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.45,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 34, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.425,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >